BIOGEN INC. Other Non-current Liabilities 2008-2026 | BIIB
Beta
What is BIOGEN INC.'s current other non-current liabilities?
BIOGEN INC. (BIIB) annual other non-current liabilities for 2025 was $748.5M, a 2.21% increase from 2024. BIOGEN INC. other non-current liabilities for the quarter ending March 31, 2026 was $787.1M.
What was BIOGEN INC.'s other non-current liabilities in 2024?
BIOGEN INC. annual other non-current liabilities for 2024 was $732.3M, a 6.25% decline from 2023.
What was BIOGEN INC.'s other non-current liabilities in 2023?
BIOGEN INC. annual other non-current liabilities for 2023 was $781.1M, a 17.27% decline from 2022.
What is BIOGEN INC.'s 5-year other non-current liabilities CAGR?
BIOGEN INC. other non-current liabilities grew at a compound annual growth rate (CAGR) of 10.86% from FY2020 to FY2025, going from $1.33B to $748.5M over 5 years.
Other Non-current Liabilities History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGR-10.9%
FY2020
$1.33B
→
FY2025
$748.5M
080910111213141516171819202122232425
5 years selected
Other Non-current Liabilities History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $748.5M | +2.2% | 10-K |
| FY2024 | $732.3M | -6.2% | 10-K |
| FY2023 | $781.1M | -17.3% | 10-K |
| FY2022 | $944.2M | -28.5% | 10-K |
| FY2021 | $1.32B | -0.7% | 10-K |
| FY2020 | $1.33B | -1.4% | 10-K |
| FY2019 | $1.35B | -2.9% | 10-K |
| FY2018 | $1.39B | -14.7% | 10-K |
| FY2017 | $1.63B | +125.4% | 10-K |
| FY2016 | $722.5M | -20.2% | 10-K |
| FY2015 | $905.8M | +39.3% | 10-K |
| FY2014 | $650.1M | -1.4% | 10-K |
| FY2013 | $659.2M | +9.1% | 10-K |
| FY2012 | $604.3M | +51.0% | 10-K |
| FY2011 | $400.3M | +22.9% | 10-K |
| FY2010 | $325.6M | +28.1% | 10-K |
| FY2009 | $254.2M | -9.3% | 10-K |
| FY2008 | $280.4M | - | 10-K |
Company: BIOGEN INC.Ticker: BIIBSector: HealthcareIndustry: Biological Products, (No Diagnostic Substances)View company profile →